Indefinite Delivery Contract 36E79724D0006
Award Date
3/15/24
Last Date to Order
3/14/25
Federal Agency
National Acquisition Center
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) awarded to Sanofi Pasteur Inc. by the National Acquisition Center, a component of the Department of Veterans Affairs (VA), is for the procurement of Influenza Virus Vaccine for the 2025-2026 influenza season. The contract has a Period of Performance from March 15, 2025 to March 14, 2026, and a ceiling value of $113,670.50. As the prime contractor, Sanofi Pasteur Inc. will provide seasonal influenza vaccines to support requirements for the VA, State...
The IDV award provides Sanofi Pasteur Inc. with an IDIQ contract vehicle to supply influenza virus vaccines and related services to federal agencies through 2024. Task orders issued to date involve delivery of vaccines by the prime contractor to locations of the Department of Veterans Affairs, Bureau of Prisons, Indian Health Service, and other government customers. Performance spans multiple years at places including Swiftwater, PA, with total task order obligations approaching $80...
The federal contract IDV award to Sanofi Pasteur Inc. is for the provision of influenza virus vaccines and related medical supplies to support various U.S. government agencies, including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, Defense Logistics Agency, Department of Health and Human Services, Department of Justice Bureau of Prisons, Smithsonian Institution, and Department of State.
The 5-year single-award IDV, valued at up to...
The National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), has awarded a single-award Indefinite Delivery Contract (IDC) to Seqirus USA Inc. for the procurement of Influenza Virus Vaccines for the 2025-2026 flu season. The $51.6 million contract has a period of performance from March 15, 2025, to March 14, 2026, and will provide vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Sanofi Pasteur Inc. for the supply of influenza vaccines. Task orders issued by VA, Federal Bureau of Prisons, Indian Health Service, and Department of Health and Human Services procure influenza virus vaccines in pre-filled syringes and multi-dose vials for individuals over 18 years old. Additional line items provide syringes tailored for those 65 and older as well as children ages 36...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The 5-year contract, valued at up to $4,023,280.80, is for the provision of Influenza Virus Vaccines in support of public health preparedness missions.
Sanofi Pasteur holds multiple IDVs with various federal agencies, including the Department of Health and Human Services, Centers for Disease Control and Prevention,...
The federal contract IDV being summarized is a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. for the delivery of adult influenza vaccines for the 2024-2025 flu season.
The $215,741,000 IDC covers a range of influenza vaccine products and presentations, including multi-dose vials, pre-filled syringes, and specialized formulations for different age groups. Seqirus, a foreign-owned for-profit manufacturer,...
The federal contract IDV award is for the supply of pediatric flu vaccines to the Centers for Disease Control and Prevention (CDC) for the 2025-2026 flu season. The prime contractor is Seqirus USA Inc., a global biotechnology company specializing in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies.
The multiple-award, indefinite delivery contract has a period of performance from December 31, 2024 to February 28, 2026 and a ceiling value...
The federal contract IDV awarded to Sanofi Pasteur Inc. is a multiple award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), with a ceiling value of $634,000,000 and a period of performance through April 14, 2027. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides a range of vaccine and pharmaceutical products to various federal agencies through this IDV and other contract vehicles.
The task orders issued under this IDV cover the...